Neurotech International Ltd
ASX:NTI

Watchlist Manager
Neurotech International Ltd Logo
Neurotech International Ltd
ASX:NTI
Watchlist
Price: 0.014 AUD -6.67% Market Closed
Market Cap: AU$14.7m

Operating Margin

-410.6%
Current
Improving
by 111.2%
vs 3-y average of -521.8%

Operating Margin shows how much profit a company makes from its regular business activities after covering operating costs. It helps measure how efficiently the company turns sales into profit.

Operating Margin
-410.6%
=
Operating Income
AU$-10.6m
/
Revenue
AU$2.6m

Operating Margin shows how much profit a company makes from its regular business activities after covering operating costs. It helps measure how efficiently the company turns sales into profit.

Operating Margin
-410.6%
=
Operating Income
AU$-10.6m
/
Revenue
AU$2.6m

Peer Comparison

Country Company Market Cap Operating
Margin
AU
Neurotech International Ltd
ASX:NTI
14.7m AUD
Loading...
US
Intuitive Surgical Inc
NASDAQ:ISRG
187.7B USD
Loading...
US
Abbott Laboratories
NYSE:ABT
184.6B USD
Loading...
US
Boston Scientific Corp
NYSE:BSX
135.6B USD
Loading...
US
Stryker Corp
NYSE:SYK
134.5B USD
Loading...
IE
Medtronic PLC
NYSE:MDT
128.9B USD
Loading...
US
Becton Dickinson and Co
NYSE:BDX
57B USD
Loading...
DE
Siemens Healthineers AG
XETRA:SHL
48.1B EUR
Loading...
US
IDEXX Laboratories Inc
NASDAQ:IDXX
55.8B USD
Loading...
US
Edwards Lifesciences Corp
NYSE:EW
48.5B USD
Loading...
US
Resmed Inc
NYSE:RMD
36.6B USD
Loading...

Market Distribution

In line with most companies in Australia
Percentile
32nd
Based on 3 951 companies
32nd percentile
-410.6%
Low
-14 949 200% — -526.4%
Typical Range
-526.4% — 6.1%
High
6.1% — 145 596.9%
Distribution Statistics
Australia
Min -14 949 200%
30th Percentile -526.4%
Median -25.2%
70th Percentile 6.1%
Max 145 596.9%

Neurotech International Ltd
Glance View

Market Cap
14.7m AUD
Industry
Health Care

Neurotech International Ltd. engages in the research, designing, marketing, and through third party manufacturers, production of wearable neurotechnology devices to assist with neurological conditions such as autism. The company is headquartered in Nedlands, Western Australia. The company went IPO on 2016-11-04. The firm operates through its wholly owned, Malta-based subsidiary AAT Research Limited. The firm is focusing on neuro-protective, anti-inflammatory and neuro-modulatory activities of NTI/Dolce cannabis strains. The firm through its class II device Mente is focused on development and commercialisation of technological solutions for the screening and treatment of symptoms associated with conditions such as autism. Mente is, a home therapy that is clinically proven to increase engagement and relaxation in autistic children with elevated Delta band brain activity.

NTI Intrinsic Value
0.005 AUD
Overvaluation 66%
Intrinsic Value
Price
What is Operating Margin?
Operating Margin shows how much profit a company makes from its regular business activities after covering operating costs. It helps measure how efficiently the company turns sales into profit.
How is Operating Margin calculated?

Operating Margin is calculated by dividing the Operating Income by the Revenue.

Operating Margin
-410.6%
=
Operating Income
AU$-10.6m
/
Revenue
AU$2.6m
What is Neurotech International Ltd's current Operating Margin?

The current Operating Margin for Neurotech International Ltd is -410.6%, which is above its 3-year median of -521.8%.

How has Operating Margin changed over time?

Over the last 3 years, Neurotech International Ltd’s Operating Margin has increased from -552.7% to -410.6%. During this period, it reached a low of -1 211.4% on Dec 31, 2022 and a high of -152% on Jun 30, 2024.

Back to Top